The role of collagen crosslinks in ageing and diabetes - The good, the bad, and the ugly

Muscles, Ligaments and Tendons Journal

Volumn 4, Issue 3, 2014, Pages 303-308

  Snedeker, Jess G ^a   Gautieri, Alfonso ^b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b ETH ZURICH   (Switzerland)

Author keywords

Advanced glycation endproducts; Ageing; Collagen; Crosslinks; Diabetes; Tendon mechanics

Indexed keywords

EID: 84940459597     PISSN: None     EISSN: 22404554     Source Type: Journal    
DOI: 10.11138/mltj/2014.4.3.303     Document Type: Review

References (73)

1. Chamberlain P, Drewello R, Korn L, et al. Construction of the Khoja Zaynuddin mosque: use of animal glue modified with urine. Archaeometry. 2011;53, 830-841.
2. Fratzl P, Weinkamer R. Nature's hierarchical materials. Progress in Material Science. 2007;52:1263-1334.
3. Fratzl, P. Springer, New York. 2008.
4. Tresoldi I, Oliva F, Benvenuto M, et al. Tendon's ultrastructure. Muscles Ligaments Tendons J. 2013;3:2-6.
5. Di Lullo GA, Sweeney SM, Korkko J, Ala-Kokko L, San Antonio JD. Mapping the ligand-binding sites and disease-associated mutations on the most abundant protein in the human, type I collagen. The Journal of biological chemistry. 2002;277:4223-4231.
6. Craig AS, Birtles MJ, Conway JF, Parry DA. An estimate of the mean length of collagen fibrils in rat tail-tendon as a function of age. Connect Tissue Res. 1989;19:51-62.
7. Bailey AJ. Molecular mechanisms of ageing in connective tissues. Mech Ageing Dev. 2001;122:735-755.
8. Haut RC. The effect of a lathyritic diet on the sensitivity of tendon to strain rate. Journal of biomechanical engineering. 1985;107:166-174.
9. Puxkandl R, et al. Viscoelastic properties of collagen: synchrotron radiation investigations and structural model. Philosophical Transactions of the Royal Society of London Series B-Biological Sciences. 2002;357:191-197.
10. Orgel JP, Wess TJ, Miller A. The in situ conformation and axial location of the intermolecular cross-linked non-helical telopeptides of type I collagen. Structure. 2000; 8:137-142.
11. Eyre DR, Weis MA, Wu JJ. Advances in collagen cross-link analysis. Methods. 2008;45: 65-74.
12. Thorpe CT, Stark RJF, Goodship AE, Birch HL. Mechanical properties of the equine superficial digital flexor. 2010;42:538-543.
13. Couppe C, Hansen P, Kongsgaard M, et al. Mechanical properties and collagen cross-linking of the patellar tendon in old and young men. Journal of Applied Physiology. 2009;107:880-886.
14. Birch HL, Wilson AM, Goodship AE. Physical activity: does long-term, high-intensity exercise in horses result in tendon degeneration? Journal of Applied Physiology. 2008;105: 1927-1933.
15. Hansen P, Haraldsson BT, Aagaard P, et al. Lower strength of the human posterior patellar tendon seems unrelated to mature collagen cross-linking and fibril morphology. J Appl Physiol. 2010;108:47-52.
16. Rigozzi S, Muller R, Snedeker JG. Collagen fibril morphology and mechanical properties of the Achilles tendon in two inbred mouse strains. Journal of anatomy. 2010;216:724-731.
17. Uzel SGM, Buehler MJ. Molecular structure, mechanical behavior and failure mechanism of the C-terminal cross-link domain in type I collagen. Journal of the Mechanical Behavior of Biomedical Materials. 2011;4:153-161.
18. Mosler E, Folkhard W, Knorzer E, Nemetschek-Gansler H, Nemetschek Th, 18 bis. M.H.J. Koch MHJ. Stress-induced molecular rearrangement in tendon collagen. Journal of molecular biology. 1985;182:589-596.
19. Willett TL, Labow RS, Aldous IG, Avery NC, Lee JM. Changes in collagen with aging maintain molecular stability after overload: evidence from an in vitro tendon model. Journal of biomechanical engineering. 2010;132.
20. Saito M, Marumo K. Collagen cross-links as a determinant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus. Osteoporosis Int. 2010;21:195-214.
21. Bank RA, Bayliss MT, Lafeber FP, Maroudas A, Tekoppele JM. Ageing and zonal variation in post-translational modification of collagen in normal human articular cartilage. The agerelated increase in non-enzymatic glycation affects biomechanical properties of cartilage. Biochem J. 1998;330:345-351.
22. Bruel A, Oxlund H. Changes in biomechanical properties, composition of collagen and elastin, and advanced glycation endproducts of the rat aorta in relation to age. Atherosclerosis. 1996;127:155-165.
23. Lai-Fook SJ, Hyatt RE. Effects of age on elastic moduli of human lungs. Journal of Applied Physiology. 2000;89:163-168.
24. Sell DR, Lapolla A, Odetti P, Fogarty J, Monnier VM. Pentosidine Formation in Skin Correlates With Severity of Complications in Individuals With Long-Standing IDDM. Diabetes. 1992;41:1286-1292.
25. Haut RC, Lancaster RL, DeCamp CE. Mechanical properties of the canine patellar tendon: some correlations with age and the content of collagen. J Biomech. 1992;25:163-173.
26. Torp S, Arridge R, Armeniades C, Baer E, Friedman B. Structure- property relationships in tendon as a function of age and effects of age and mechanical deformation on the ultrastructure of tendon. Colston Papers. 1974;26:197-249.
27. Avery NC, Bailey AJ. The effects of the Maillard reaction on the physical properties and cell interactions of collagen. Pathologie Biologie. 2006;54:387-395.
28. Avery NC, Bailey AJ. Enzymic and non-enzymic cross-linking mechanisms in relation to turnover of collagen: relevance to aging and exercise. Scand J Med Sci Sports. 2005;15: 231-240.
29. Avery NC, Bailey AJ. The effects of the Maillard reaction on the physical properties and cell interactions of collagen. Pathol Biol. 2006;54:387-395.
30. Andreassen TT, Seyerhansen K, Bailey AJ. Thermal-Stability, Mechanical-Properties and Reducible Cross-Links of Rat Tail Tendon in Experimental Diabetes. Biochimica Et Biophysica Acta. 1981;677:313-317.
31. Schnider SL, Kohn RR. Effects of Age and Diabetes-Mellitus on the Solubility of Collagen from Human-Skin, Tracheal Cartilage and Dura Mater. Exp Gerontol. 1982;17:185-194.
32. Ahmed N. Advanced glycation endproducts—role in pathology of diabetic complications. Diabetes research and clinical practice. 2005;67:3-21.
33. Grandhee SK, Monnier VM. Mechanism of Formation of the Maillard Protein Cross-Link Pentosidine - Glucose, Fructose, and Ascorbate as Pentosidine Precursors. Journal of Biological Chemistry. 1991;266:11649-11653.
34. Sell DR, Biemel KM, Reihl O, Lederer MO, Strauch CM, Monnier VM. Glucosepane is a major protein cross-link of the senescent human extracellular matrix. Relationship with diabetes. The Journal of biological chemistry. 2005;280:12310-12315.
35. Monnier VM, Mustata GT, Biemel KL, et al. Cross-linking of the extracellular matrix by the Maillard reaction in aging and dia- betes - An update on "a puzzle nearing resolution". Ann Ny Acad Sci. 2005;1043:533-544.
36. Bailey AJ, Paul RG, Knott L. Mechanisms of maturation and ageing of collagen. Mechanisms of Ageing and Development. 1998;106:1-56.
37. Bedi A, Fox AJ, Harris PE, et al. Diabetes mellitus impairs tendon- bone healing after rotator cuff repair. Journal of Shoulder and Elbow Surgery. 2010;19:978-988.
38. Frank C, McDonald D, Wilson J, Eyre D, Shrive N. Rabbit medial collateral ligament scar weakness is associated with decreased collagen pyridinoline crosslink density. Journal of Orthopaedic Research. 1995;13:157-165.
39. Gautieri A, Redaelli A, Buehler MJ, Vesentini S. Age- and diabetes- related nonenzymatic crosslinks in collagen fibrils: Candidate amino acids involved in Advanced Glycation End-products. Matrix Biology. 2013.
40. Vesentini S, Redaelli A, Gautieri A. Nanomechanics of collagen microfibrils. Muscles Ligaments Tendons J. 2013;3:23-34.
41. Reigle KL, Di Lullo G, Turner KR, et al. Non-enzymatic glycation of type I collagen diminishes collagen-proteoglycan binding and weakens cell adhesion. J Cell Biochem. 2008;104:1684-1698.
42. Yan SF, Ramasamy R, Schmidt AM. Mechanisms of Disease: advanced glycation end-products and their receptor in inflammation and diabetes complications. Nat Rev Endocrinol. 2008;4:285-293.
43. Galeski A, Kastelic J, Baer E, Kohn RR. Mechanical and structural changes in rat tail tendon induced by alloxan diabetes and aging. Journal of Biomechanics. 1977;10:775-782.
44. Fox AJ, Bedi A, Deng XH, et al. Diabetes mellitus alters the mechanical properties of the native tendon in an experimental rat model. Journal of Orthopaedic Research. 2011;29: 880-885.
45. Reddy GK, Stehno-Bittel L, Enwemeka CS. Glycation-induced matrix stability in the rabbit Achilles tendon. Archives of Biochemistry and Biophysics. 2002;399:174-180.
46. Reddy GK. Cross-linking in collagen by nonenzymatic glycation increases the matrix stiffness in rabbit Achilles tendon. Experimental Diabesity Research. 2004;5:143-153.
47. de Oliveira RR, de Lira KD, Silveira PV, et al. Mechanical Properties of Achilles Tendon in Rats Induced to Experimental Diabetes. Annals of Biomedical Engineering. 2011;1-7.
48. Lancaster RL, Haut RC, DeCamp CE. Changes in the mechanical properties of patellar tendon preparations of spontaneously diabetic dogs under long-term insulin therapy. J Biomech. 1994;27:1105-1108.
49. Goh KL, Holmes DF, Lu HY, et al. Ageing changes in the tensile properties of tendons: influence of collagen fibril volume fraction. Journal of biomechanical engineering. 2008;130.
50. Dressler MR, Butler DL, Wenstrup R, Awad HA, Smith F, Boivin GP. A potential mechanism for age-related declines in patellar tendon biomechanics. Journal of Orthopaedic Research. 2002;20:1315-1322.
51. Blevins FT, Hecker AT, Bigler GT, Boland AL, Hayes WC. The Effects of Donor Age and Strain Rate on the Biomechanical Properties of Bone-Patellar Tendon-Bone Allografts. The American Journal of Sports Medicine. 1994;22:328-333.
52. Lewis G, Shaw KM. Tensile properties of human tendo achillis: Effect of donor age and strain rate. The Journal of Foot and Ankle Surgery. 1997;36:435-445.
53. Kent MJ, Light ND, Bailey AJ. Evidence for glucose-mediated covalent cross-linking of collagen after glycosylation in vitro. Biochem J. 1985;225:745-752.
54. Bai PM, Phua K, Hardt T, Cernadas M, Brodsky B. Glycation alters collagen fibril organization. Connect Tissue Res. 1992;28:1-12.
55. Singh R, Barden A, Mori T, Beilin L. Advanced glycation endproducts: a review. Diabetologia. 2001;44:129-146.
56. Goldin A, Beckman JA, Schmidt AM, Creager MA. Advanced Glycation End Products: Sparking the Development of Diabetic Vascular Injury. Circulation. 2006;114:597-605.
57. Sell DR, Monnier VM. Molecular basis of arterial stiffening: role of glycation - a mini-review. Gerontology. 2012;58:227-237.
58. Monnier VM, Mustata GT, Biemel KL, et al. Cross-Linking of the Extracellular Matrix by the Maillard Reaction in Aging and Diabetes: An Update on "a Puzzle Nearing Resolution". Annals of the New York Academy of Sciences. 2005;1043:533-544.
59. Sjoberg JS, Bulterijs S. Characteristics, formation, and pathophysiology of glucosepane: a major protein cross-link. Rejuvenation Res. 2009;12:137-148.
60. Vasan S, Zhang X, Zhang X, et al. An agent cleaving glucosederived protein crosslinks in vitro and in vivo. Nature. 1996;382:275-278.
61. Wolffenbuttel BH, Boulanger CM, Crijns FR, et al. Breakers of advanced glycation end products restore large artery properties in experimental diabetes. Proceedings of the National Academy of Sciences. 1998;95:4630-4634.
62. Susic D. Cross-link breakers as a new therapeutic approach to cardiovascular disease. Biochem Soc Trans. 2007;35:853-856.
63. Monnier VM, Wu X. Enzymatic deglycation with amadoriase enzymes from Aspergillus sp. as a potential strategy against the complications of diabetes and aging. Biochem Soc Trans. 2003;31:1349-1353.
64. Wu X, Monnier VM. Enzymatic deglycation of proteins. Arch Biochem Biophys. 2003;419: 16-24.
65. Mennella C, Borrelli RC, Vinale F, Ruocco M, Fogliano V. Substrate specificity of amadoriase I from Aspergillus fumigatus. Ann Ny Acad Sci. 2005;1043:837-844.
66. Capuano E, Fedele F, Mennella C, et al. Studies on the effect of amadoriase from Aspergillus fumigatus on peptide and protein glycation in vitro. J Agr Food Chem. 2007;55:4189-4195.
67. Lin ZL, Zheng J. Occurrence, characteristics, and applications of fructosyl amine oxidases (amadoriases). Appl Microbiol Biot. 2010;86:1613-1619.
68. Takahashi M, Pischetsrieder M, Monnier VM. Isolation, purification, and characterization of amadoriase isoenzymes (fructosyl amine-oxygen oxidoreductase EC 1.5.3) from Aspergillus sp. Journal of Biological Chemistry. 1997;272:3437-3443.
69. Zheng J, Guan H, Xu LH, Yang R, Lin ZL. Engineered amadoriase II exhibiting expanded substrate range. Appl Microbiol Biot. 2010;86:607-613.
70. Qian Y, Zheng J, Lin ZL. Loop engineering of amadoriase II and mutational cooperativity. Appl Microbiol Biot. 2013;97:8599-8607.
71. Collard F, Zhang J, Nemet I, Qanungo KR, Monnier VM, Yee VC. Crystal structure of the deglycating enzyme fructosamine oxidase (amadoriase II). The Journal of biological chemistry. 2008;283:27007-27016.
72. Li Y, Fessel G, Georgiadis M, Snedeker JG. Advanced glycation end-products diminish tendon collagen fiber sliding. Matrix biology: journal of the International Society for Matrix Biology. 2013;32:169-177.
73. Padulo J, Oliva F, Frizziero A, Maffulli N. Muscles, Ligaments and Tendons Journal. Basic principles and recommendations in clinical and field science research. MLTJ. 2013;4: 250-252.